Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.

Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that can lead to cirrhosis, liver transplant, and even hepatocellular carcinoma. While liver biopsy remains the reference standard for disease diagnosis, analytical and clinical development of non-invasive soluble biomarkers of NASH are...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Sumit Kar, Sabina Paglialunga, Sharon H Jaycox, Rafiqul Islam, Angelo H Paredes
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0217263